NCT00026364View on ClinicalTrials.gov

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2006

Conditions
Colorectal Cancer
Interventions
DRUG

fluorouracil

DRUG

gefitinib

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

Trial Locations (2)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026364 - ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter